E

Enzymatica AB (publ)
STO:ENZY

Watchlist Manager
Enzymatica AB (publ)
STO:ENZY
Watchlist
Price: 3.05 SEK 2.01%
Market Cap: 740.4m SEK

Wall Street
Price Targets

ENZY Price Targets Summary
Enzymatica AB (publ)

There are no price targets for ENZY.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Enzymatica AB (publ) Competitors:
Price Targets
TORNTPHARM
Torrent Pharmaceuticals Ltd
6% Upside
AJANTPHARM
Ajanta Pharma Ltd
15% Upside
300357
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd
12% Upside
JNJ
Johnson & Johnson
11% Upside
VRCA
Verrica Pharmaceuticals Inc
401% Upside
688166
BrightGene Bio-Medical Technology Co Ltd
35% Downside
3692
Hansoh Pharmaceutical Group Company Ltd
14% Downside
HITI
High Tide Inc
118% Upside

Revenue
Forecast

Revenue Estimate
Enzymatica AB (publ)

For the last 8 years the compound annual growth rate for Enzymatica AB (publ)'s revenue is 3%. The projected CAGR for the next 2 years is 56%.

3%
Past Growth
56%
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Enzymatica AB (publ)

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
19%
Average Beat

Net Income
Forecast

Net Income Estimate
Enzymatica AB (publ)

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-26%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ENZY's stock price target?
Not Available

ENZY doesn't have any price targets made by Wall Street professionals.

What is Enzymatica AB (publ)'s Revenue forecast?
Projected CAGR
56%

For the last 8 years the compound annual growth rate for Enzymatica AB (publ)'s revenue is 3%. The projected CAGR for the next 2 years is 56%.

Back to Top